Frontiers Journal of Cardiology & Cardiovascular Medicine

DEBATES AND CHALLENGES IN THE MANAGEMENT OF CARDIOGENIC SHOCK DUE TO ST ELEVATION MYOCARDIAL INFARCTION

Abstract

Cardiogenic shock is a complex hemodynamically complex syndrome characterized by reduced cardiac output that often culminates in multi-organ failure and death. Despite recent advances, clinical outcomes remain poor, with mortality rates exceeding 40%. Vascular remodeling, vasopressors, anticonvulsants, fluids, mechanical circulation support, and general intensive care measures are widely used for the management of CS. However, there is only limited evidence for any of the treatment strategies listed above except for remodeling and the relative ineffectiveness of intra-aortic balloon infusion. A few experiments were completed and a randomized clinical trial focused on these patients, reflecting the challenges of conducting trials in this severely ill population. We have little evidence to guide treatment. As a result, the controversy surrounding treatment strategies is more common in these patients than conclusions

COPYRIGHT© FRONTIERSMEETINGS 2019. ALL RIGHTS RESERVED | TERMS AND CONDITIONS